Skip to content

Renalytix plc

RENXF RNLXY

CIK 0001811115

← back to feed
Revenue (TTM)
$100K
Q1 Nov 2024
Net Income (TTM)
−$31.11M
+26.6% YoY Q1 Nov 2024
EPS Diluted (TTM)
−$0.32
+43.6% YoY Q1 Nov 2024
Gross Margin
220.0%
Q1 Nov 2024
Operating Margin
-28,176.0%
Q1 Nov 2024
Net Margin
-31,110.0%
Q1 Nov 2024
Free Cash Flow (TTM)
−$30.11M
Q1 Nov 2024
Cash
$909K
Q1 Nov 2024
Total Debt
—
Q1 Nov 2024
Shares Outstanding
331.21M sh
Q1 Nov 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings